Evidence map›Paper›PMID 35802616›Full record

ArticlePloS one2022

High prevalence of Panton-Valentine leukocidin positive, multidrug resistant, Methicillin-resistant Staphylococcus aureus strains circulating among clinical setups in Adamawa and Far North regions of Cameroon.

Mansour Mohamadou, Sarah Riwom Essama, Marie Chantal Ngonde Essome, Lillian Akwah, Nudrat Nadeem, Hortense Gonsu Kamga, Sadia Sattar, Sundus Javed

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Genome sequence of multi-drug-resistantMicrobiology resource announcements · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Molecular detection ofTherapeutic advances in infectious disease
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mansour MohamadouBiosciences Department, COMSATS University Islamabad, Islamabad, Pakistan.
Sarah Riwom EssamaDepartment of Microbiology, Faculty of Science, University of Yaounde 1, Yaoundé, Cameroon.
Marie Chantal Ngonde EssomeCentre for Research on Health and Priority Pathologies, Institute of Medical Research and Medicinal Plants Studies, Yaoundé, Cameroon.
Lillian AkwahDepartment of Microbiology, Faculty of Science, University of Yaounde 1, Yaoundé, Cameroon.
Nudrat NadeemBiosciences Department, COMSATS University Islamabad, Islamabad, Pakistan.
Hortense Gonsu KamgaDepartment of Microbiology, Haematology and Infectious diseases, Faculty of Medicine and Biomedical Sciences of University of Yaounde 1, Yaoundé, Cameroon.
Sadia SattarBiosciences Department, COMSATS University Islamabad, Islamabad, Pakistan.
Sundus JavedBiosciences Department, COMSATS University Islamabad, Islamabad, Pakistan.ORCID 0000-0001-8352-8078
Université de Yaoundé I · CMCOMSATS University Islamabad · PKMinistry of Scientific Research and Innovation · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Staphylococcus aureus (S. aureus) is one of the earliest pathogens involved in human infections, responsible for a large variety of pathologies. Methicillin was the first antibiotic used to treat infections due to S. aureus but infections due to Methicillin resistant Staphylococcus aureus (MRSA) originated from hospital settings. Later, severe infections due to MRSA without any contact with the hospital environment or health care workers arose. Prevalence of MRSA has shown an alarming increase worldover including Cameroon. This Cross-sectional study was designed to evaluate the occurrence of MRSA infections in five different, most frequented Hospitals in northern Cameroon. Socio demographic data was recorded through questionnaire and different clinical specimens were collected for bacterial isolation. Identification of S. aureus was confirmed via 16s rRNA amplification using S. aureus specific primers. Molecular characterisation was performed through mecA gene, Luk PV gene screening and SCCmec typing. A total of 380 S. aureus clinical isolates were obtained of which 202 (53.2%) were nonduplicate multidrug resistant isolates containing, 45.5% MRSA. Higher number of MRSA was isolated from pus (30.4%) followed by blood culture (18.5%), and urine (17.4%). Patients aged 15 to 30 years presented high prevalence of MRSA (30.4%). Majority isolates (97.8%) carried the mecA gene, PVL toxin screening indicated 53.3% isolates carried the lukPV gene. Based on PVL detection and clinical history, CA-MRSA represented 53.3% of isolates. SCCmec typing showed that the Type IV was most prevalent (29.3%), followed by type I (23.9%). Amongst MRSA isolates high resistance to penicillin (91.1%), cotrimoxazole (86.7%), tetracycline (72.2%), and ofloxacin (70.0%) was detected. Meanwhile, rifampicin, fusidic acid, lincomycin and minocycline presented high efficacy in bacterial control. This study revealed a high prevalence of MRSA among infections due to S. aureus in Northern Cameroon. All MRSA recorded were multidrug resistant and the prevalence of CA MRSA are subsequently increasing, among population.

Indexed as

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsBacterial ProteinsBacterial ToxinsCameroonCross-Sectional StudiesExotoxinsHumansLeukocidinsPenicillin-Binding ProteinsPrevalenceRNA, Ribosomal, 16SStaphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsBacterial ToxinsExotoxinsLeukocidinsPanton-Valentine leukocidinPenicillin-Binding ProteinsRNA, Ribosomal, 16S

Identifiers

PMID35802616
PMCPMC9269376
OpenAlexW4284969872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.